This includes, among others, the commercialization of selective serotonin reuptake inhibitors (SSRIs) for depression and anxiety-related disorders and of psychostimulants like methylphenidate (well known under the trade name Ritalin) for ADHD as well as the use of these and other substances, such as modafinil (indicated for the treatment of narcolepsy), for recreational and enhancement purposes.
Download the article by Williams, Katz and Martin below:
Structure of Fluoxetine, a common type of SSRI
Structure of Methylphenidate
Inspired by the homonymous book by Fernando Vidal and Francisco Ortega, this timespace presents the authors' genealogy of the cerebral subject and the influence of the neurological discourse in human sciences, mental health and culture.